BD & LICENSING

 

Over the years, the pharmaceutical sector has undergone radical changes, indeed, the increasing costs of R&D, the increasingly stringent regulation and the diffusion of generic drugs have pushed pharmaceutical companies to review the business model in order to acquire new competitive advantages and continue to innovate.

Licensing agreements have proved to be a crucial tool for responding to this selective pressure, which is why this type of agreement has been adopted more and more widely among pharmaceutical companies.

The main advantages are:

  • innovate by reducing risks
  • reduce the "time to market"
  • quickly gain a competitive advantage
  • penetrare nuovi mercati
  • create a network of consolidated partners to draw on for future projects

 

The partners of D&V FARMA make available, through licensing agreements, an innovative product portfolio for pharmaceutical companies worldwide.

EYE DROPS

EYE DROPS 1

read more

Thanks to the synergistic action of its components, it treats the sign and symptoms linked to ocular surface alterations in diabetic patients: dry eye, recurrent erosions of the corneal epithelium, loss of corneal sensitivity and corneal neuropathy.

Regulatory status: Certified medical device class IIb
Intellectual properties: Patent pending
Evidence: Clinical and preclinical
Contact lens compatibility: Compatible with contact lens
Packaging:
– Multidose
– Multidose preservative free

EYE DROPS 2

read more

It protects the corneal epithelium and promotes the epithelial physiological repairing process, it reduces corneal surface irregularities It creates a protective film to avoid tear evaporation, it promotes ocular surface lubrication and healing and protects the eye from the daily exposure to UV light

Regulatory status: Certified medical device class IIb
Intellectual properties: Paent pending
Evidence: Clinical and preclinical
Contact lens compatibility: Compatible with contact lens
Packaging:
– Multidose
– Multidose preservative free

EYE DROPS 3

read more

It protects the eye from the damages induced by UV and Blu light Anterior segment: Photo-keratitis and photo-keratoconjunctivitis. Posterior segment: AMD

Regulatory status: Certified medical device class IIb and Personal Protective Equipment
Intellectual properties: Patented
Evidence: preclinical
Contact lens compatibility: Compatible with contact lens
Packaging: Multidose preservative free

EYE DROPS 4

read more

Antioxidant solution that protects the crystalline lens from photo-oxidative damage, as a result, it preserves the lens’ transparency

Regulatory status: Certified medical device class IIb
Intellectual properties: Patented
Evidence: preclinical
Contact lens compatibility: Compatible with contact lens
Packaging: Multidose preservative free

EYE DROPS 5

read more

The ophthalmic solution has a protective and lubricant action on corneal epithelium and accelerates the natural repairing process in dry eye. It is a valid support for patients affected by keratoconus, or undergoing corneal crosslinking.

Regulatory status: Certified medical device class IIb 
Intellectual properties: Patented 
Contact lens compatibility: Compatible with contact lens
Packaging: Multidose preservative free

EYE DROPS 6

read more

Eye drops useful as pre- and post-operative prophylaxis of cataract, glaucoma surgery and intravitreal injections.

Regulatory status: Certified medical device class IIb 
Intellectual properties: Patented 
Evidence: clinical and preclinical 
Contact lens compatibility: Compatible with contact lens
Packaging: Multidose

EYE DROPS 7

read more

Hyposmolar gel for dry eye syndrome based on a new chemical entity. Indicated for Dry Eye (mild to severe) and patients with a need for lubrication and reduction of oxidative stress on the ocular surface. Preservative and emulsifier free

Regulatory status: Certified medical device class IIb 
Intellectual properties: Patented 
Contact lens compatibility: Compatible with contact lens
Packaging: Multidose preservative free

EYE DROPS 8

read more

It is a hypertonic solution for corneal oedema. While most of the competitors take care only of the corneal oedema, our product takes care of two different targets i.e. corneal oedema and it exerts nourishing and antioxidant action and provides photo oxidative protection.

Regulatory status: Certified medical device class IIb 
Intellectual properties: Patented 
Contact lens compatibility: Compatible with  contact lens
Packaging: Multidose preservative free

SURGICAL

Cross-linking equipment

read more

EPI-OFF, EPI-ON: 
CXL Continuous and pulsed
User presets
Regulatory status: Certified medical device class IIb 

RIBO 1

read more

1.5ml prefilled sterile Syringe 
Containing Riboflavin and Dextran.
The formulation further contains a penetration enhancer, and it can be used with every CXL protocol and most UV devices on the market

Regulatory status: Certified medical device class IIa 
Intellectual properties: Patented 
Evidence: clinical 

RIBO 2

read more

1.5ml prefilled sterile Syringe 
Containing Riboflavin and Dextran.
The formulation further contains a penetration enhancer, and it can be used with every CXL protocol and most UV devices on the market

Regulatory status: Certified medical device class IIa 
Intellectual properties: Patented 
Evidence: clinical 

DYE 1

read more

It is a sterile solution for vitreous tissue staining in vitreoretinal surgery 
Advantages:

      • Precise visualization and identification of vitreous 
      • Protective and shielding action
      • Increased safety

Regulatory status: Certified medical device class IIa 
Intellectual properties: Patented
0.5ml prefilled sterile Syringe

DYE 2

read more

It is a sterile solution for epiretinal (ERM) and internal limiting membrane (ILM) staining during vitreoretinal surgery
Advantages:

      • Fast and precise membrane visualization
      • Protective and shielding action
      • Increased safety

Regulatory status: Certified medical device class IIa 
Intellectual properties: Patented
Packaging: 0.5ml prefilled sterile Syringe

DYE 3

read more

Sterile solution for anterior capsule staining during cataract surgery, glaucoma surgery, and corneal transplants

Regulatory status: Certified medical device class IIa 
Intellectual properties: Patented
Packaging: 0.5ml prefilled sterile Syringe

VISCO 1

read more

Visco-surgical devices for intraocular use that create and maintain the anterior chamber space, and protect endothelial cells during the procedures.

Regulatory status: Certified medical device class IIa 
Intellectual properties: Patented
Packaging: 0.8ml prefilled sterile Syringe

DIAGNOSTIC

DIAGNOSTIC 1

read more

Patented eye stain patient friendly alternative to fluorescein

Regulatory status: Certified medical device class IIa 
Intellectual properties: Patented
Packaging: Multidose dispenser and single dose viale
Evidence: clinical